產品詳情
查看大圖

  • 產品名稱：ATCC 25285 脆弱擬杆菌

  • 產品型號：ATCC 25285
  • 產品廠商：其它品牌
  • 產品文檔：
你添加了1件商品 查看購物車
簡單介紹：
簡單介紹 ATCC 25285 脆弱擬杆菌，現貨供應 ATCC 菌種 上海桑戈生物公司現貨供應美國典型培養物保藏中心(ATCC)菌種。,*低價格,所謂"踏破鐵鞋無覓處.得來全不費工夫!"聯係電話021-55221162手機 13661616642郵箱sangerbio @hotmail.com.歡迎各位老師來電谘! 美國菌種保藏中心
詳情介紹：

ATCC 25285 脆弱擬杆菌 的詳細介紹
ATCC 25285 脆弱擬杆菌
ATCC® Number:   25285™        
Preceptrol® Culture  
Organism:  Bacteroides fragilis (Veillon and Zuber) Castellani and Chalmers 
Designations:  VPI 2553 [EN-2; NCTC 9343]  
Isolation:  Appendix abscess  
Depositor:  WE Moore  
History:  ATCC <<--WE Moore<<--A. Sonnenwirth EN-2 <<--- NCTC 9343 <<--- L. Garrod  
Biosafety Level:  2  
Shipped:  freeze-dried  
Growth Conditions:  ATCC medium1490: Modified chopped meat medium
Temperature: 37.0°C 
Duration: anaerobic  
Permits/Forms:  In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.  
Cross References:  Nucleotide (GenBank) : AF280705 Bacteroides fragilis isolate ATCC 25285 RecA (recA) gene, partial cds.
Nucleotide (GenBank) : AX110196 Sequence 929 from Patent WO0123604.
Nucleotide (GenBank) : X83935 B.fragilis 16S rRNA (ATCC 25285T).
Nucleotide (GenBank) : CR626927Bacteroides fragilis NCTC 9343, complete genome.
Nucleotide (GenBank) : AF280642 Bacteroides fragilis isolate ATCC 25285 glutamine synthetase (glnA) gene, partial cds.
Nucleotide (GenBank) : U05887 Bacteroides fragilis ATCC 25285 beta-lactamase (cepA-85) gene, complete cds.  
Type Strain:  yes(type strain)  
Comments:  Genome sequenced strain  
Applications:  media testing [92430] [21529] 
quality control [92216] 
quality control strain [92125] [92162] [92152] 
susceptibility testing [21527] 
quality control strain for BBL and MicroScan [Reg TM] products  
Related Products:  purified DNA:ATCC 25285D  
References:  6005: Cato EP, Johnson JL. Reinstatement of species rank for Bacteroides fragilis, B. ovatus, B. distasonis, B. thetaiotaomicron, and B. vulgatus: Designation of neotype strains for Bacteroides fragilis (Veillon and Zuber) Castellani and Chalmers and Bacteroides thetaiotaomicron (Distaso) Castellani and Chalmers. Int. J. Syst. Bacteriol. 26: 230-237, 1976.
21527: CLSI Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M11-A7.
21529: CLSI Quality Control for Commercially Prepared Microbiological Culture Media; Approved Standard - 3rd Edition. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M22-A3.
36887: Skerman VB, et al. Approved lists of bacterial names. Int. J. Syst. Bacteriol. 30: 225-420, 1980.
39924: Takahata M, Nishino T. Antibacterial activities of tosufloxacin against anaerobic bacteria and the electron micrograph of its bactericidal effects. Chemotherapy 43: 153-158, 1997. PubMed: 9142454
92125: BD Crystal ANR. :BD Becton Dickinson;Crystal
92152: MicroScan Rapid Anaerobic Panel. :Dade Behring;MicroScan
92162: Sensititre Anaerobe MIC Susceptibility. :Trek Diagnostic Systems;Sensititre
92216: CLSI Quality Control of Microbiological Transport Systems; Approved Standard. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M40-A.
92430: Medical microbiology--Culture media -- Part 4: Transport systems for specimens containing bacteria. Berlin, Germany:Deutsches Institut fur Normung;DIN DIN 58942-4: 2003, 2003 

滬公網安備 31010902002433號